AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 280: E23-E30, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (53)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boden, G.
Right arrow Articles by Stein, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boden, G.
Right arrow Articles by Stein, T. P.
Vol. 280, Issue 1, E23-E30, January 2001

Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus

Guenther Boden1, Xinhua Chen1, and T. Peter Stein2

1 Division of Endocrinology/Diabetes/Metabolism and the General Clinical Research Center, Temple University Hospital, Philadelphia, Pennsylvania 19140; and the 2 Department of Surgery, University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, Stratford, New Jersey 08084

We tested the generally accepted concept that increased gluconeogenesis (GNG) and endogenous glucose production (EGP) are the main reasons for postabsorptive hyperglycemia in patients with type 2 diabetes mellitus (T2DM). GNG was measured with the 2H2O method by use of both the C5-to-C2 ratio (C5/C2, with gas chromatography-mass spectrometry) and the C5-to-2H2O ratio (C5/2H2O, with isotope ratio mass spectrometry), and EGP was measured with 3-[3H]glucose in 27 patients with T2DM [13 with fasting plasma glucose (FPG) >10 mM and 14 with FPG <10 mM] and in 7 weight- and age-matched nondiabetic controls. The results showed 1) that GNG could be determined accurately with 2H2O by using either C5/C2 or C5/2H2O; 2) that whereas after an overnight fast of 16 h, GNG was higher in the entire group of patients with T2DM than in controls (6.4 vs. 5.0 µmol · kg-1 · min-1 or 60.4 vs. 51.4% of EGP, P < 0.02), GNG was within normal limits (less than the mean ± 2 SD of controls or <65.3%) in 11/14 (79%) patients with mild to moderate hyperglycemia (FPG <10 mM) and in 5/13 (38%) of patients with severe hyperglycemia (FPG 10-20 mM); 3) that elevated GNG in T2DM was associated with a 43% decrease in prehepatic insulin secretion, i.e., with hepatic insulin deficiency; and 4) that FPG correlated significantly with glucose clearance (insulin resistance) (r = 0.70) and with GNG (r = 0.50) or EGP (r = 0.45). We conclude 1) that peripheral insulin resistance is at least as important as GNG (and EGP) as a cause of postabsorptive hyperglycemia in T2DM and 2) that GNG and EGP in T2DM are increased under conditions of significant hepatic insulin deficiency and thus probably represent a late event in the course of T2DM.

endogenous glucose production; insulin resistance; prehepatic insulin secretion; deuterated water method


This article has been cited by other articles:


Home page
DiabetesHome page
R. Basu, V. Chandramouli, B. Dicke, B. R. Landau, and R. A. Rizza
Plasma C5 Glucose-to-2H2O Ratio Does Not Provide an Accurate Assessment of Gluconeogenesis During Hyperinsulinemic-Euglycemic Clamps in Either Nondiabetic or Diabetic Humans
Diabetes, July 1, 2008; 57(7): 1800 - 1804.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Bock, W. C. Schumann, R. Basu, S. C. Burgess, Z. Yan, V. Chandramouli, R. A. Rizza, and B. R. Landau
Evidence That Processes Other Than Gluconeogenesis May Influence the Ratio of Deuterium on the Fifth and Third Carbons of Glucose: Implications for the Use of 2H2O to Measure Gluconeogenesis in Humans
Diabetes, January 1, 2008; 57(1): 50 - 55.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Bock, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, V. Chandramouli, B. R. Landau, and R. A. Rizza
Contribution of Hepatic and Extrahepatic Insulin Resistance to the Pathogenesis of Impaired Fasting Glucose: Role of Increased Rates of Gluconeogenesis
Diabetes, June 1, 2007; 56(6): 1703 - 1711.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. S. Jin, B.-H. Park, A. D. Sherry, and C. R. Malloy
Role of Excess Glycogenolysis in Fasting Hyperglycemia Among Pre-Diabetic and Diabetic Zucker (fa/fa) Rats
Diabetes, March 1, 2007; 56(3): 777 - 785.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Kishore, J. Tonelli, S. Koppaka, C. Fratila, A. Bose, D.-E. Lee, K. Reddy, and M. Hawkins
Time-Dependent Effects of Free Fatty Acids on Glucose Effectiveness in Type 2 Diabetes
Diabetes, June 1, 2006; 55(6): 1761 - 1768.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Chevalier, S. C. Burgess, C. R. Malloy, R. Gougeon, E. B. Marliss, and J. A. Morais
The Greater Contribution of Gluconeogenesis to Glucose Production in Obesity Is Related to Increased Whole-Body Protein Catabolism
Diabetes, March 1, 2006; 55(3): 675 - 681.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Ercan-Fang, M. R. Taylor, J. L. Treadway, C. B. Levy, P. E. Genereux, E. M. Gibbs, V. L. Rath, Y. Kwon, M. C. Gannon, and F. Q. Nuttall
Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors
Am J Physiol Endocrinol Metab, September 1, 2005; 289(3): E366 - E372.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Krssak, A. Brehm, E. Bernroider, C. Anderwald, P. Nowotny, C. D. Man, C. Cobelli, G. W. Cline, G. I. Shulman, W. Waldhausl, et al.
Alterations in Postprandial Hepatic Glycogen Metabolism in Type 2 Diabetes
Diabetes, December 1, 2004; 53(12): 3048 - 3056.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Basu, A. Basu, C. M. Johnson, W. F. Schwenk, and R. A. Rizza
Insulin Dose-Response Curves for Stimulation of Splanchnic Glucose Uptake and Suppression of Endogenous Glucose Production Differ in Nondiabetic Humans and Are Abnormal in People With Type 2 Diabetes
Diabetes, August 1, 2004; 53(8): 2042 - 2050.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Basu, W. F. Schwenk, and R. A. Rizza
Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E55 - E62.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. W. Franks, U. Ekelund, S. Brage, M.-Y. Wong, and N. J. Wareham
Does the Association of Habitual Physical Activity With the Metabolic Syndrome Differ by Level of Cardiorespiratory Fitness?
Diabetes Care, May 1, 2004; 27(5): 1187 - 1193.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
O. Kunert, H. Stingl, E. Rosian, M. Krssak, E. Bernroider, W. Seebacher, K. Zangger, P. Staehr, V. Chandramouli, B.R. Landau, et al.
Measurement of Fractional Whole-Body Gluconeogenesis in Humans From Blood Samples Using 2H Nuclear Magnetic Resonance Spectroscopy
Diabetes, October 1, 2003; 52(10): 2475 - 2482.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Altomonte, A. Richter, S. Harbaran, J. Suriawinata, J. Nakae, S. N. Thung, M. Meseck, D. Accili, and H. Dong
Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E718 - E728.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Adkins, R. Basu, M. Persson, B. Dicke, P. Shah, A. Vella, W. F. Schwenk, and R. Rizza
Higher Insulin Concentrations Are Required to Suppress Gluconeogenesis Than Glycogenolysis in Nondiabetic Humans
Diabetes, September 1, 2003; 52(9): 2213 - 2220.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Katanik, B. J. McCabe, D. Z. Brunengraber, V. Chandramouli, F. J. Nishiyama, V. E. Anderson, and S. F. Previs
Measuring gluconeogenesis using a low dose of 2H2O: advantage of isotope fractionation during gas chromatography
Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E1043 - E1048.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Boden, P. Cheung, and C. Homko
Effects of Acute Insulin Excess and Deficiency on Gluconeogenesis and Glycogenolysis in Type 1 Diabetes
Diabetes, January 1, 2003; 52(1): 133 - 137.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. Boden, P. Cheung, T. P. Stein, K. Kresge, and M. Mozzoli
FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis
Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E12 - E19.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Ercan-Fang, M. C. Gannon, V. L. Rath, J. L. Treadway, M. R. Taylor, and F. Q. Nuttall
Integrated effects of multiple modulators on human liver glycogen phosphorylase a
Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E29 - E37.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. R. Landau
Methods for measuring glycogen cycling
Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E413 - E419.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Boden, X. Chen, E. Capulong, and M. Mozzoli
Effects of Free Fatty Acids on Gluconeogenesis and Autoregulation of Glucose Production in Type 2 Diabetes
Diabetes, April 1, 2001; 50(4): 810 - 816.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online